Fuse Biotherapeutics

Developer of immune-modulating therapies for the treatment of cancer

placeLos Angeles, California, United States calendar_todayFounded 2021 groups12 employees language fusebiotx.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 12 times.

YearFilings
20244
20254
20262

Investor mix

5 investors on record; lead investors include Viva BioInnovator.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon